illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. AK medicals
Company logo

AK medicals | Sustainability Performance

https://www.ak-medical.net/en

Develops and commercializes medical devices and diagnostic equipment within the healthcare technology sector.

2003

China

501 - 1,000 employees

Medical Device

$100M - 500M in revenue

$25M - 100M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#6270
Overall
#112
in China
#96
in Medical Device

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

151 out of 174

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projectionsAsset manager exclusion

View similiar companies

Company logo
BioKangtai

China, Health Care, Biotechnology

Company logo
Shandong Buchang Pharmaceuticals

China, Health Care, Pharmaceuticals

Company logo
INT Medical Instruments

China, Health Care, Medical Device

Market cap

6.4B $, 2026▼2.2% YoY

Revenue

1.3B $, 2024▼18.8% YoY

R&D intensity

10.33% 2024

Controversy level

Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

6.4B $, 2026▼2.2% YoY

Revenue

1.3B $, FY2024▼18.8% YoY

EBITDA

300.0M $, FY2024▼9.1% YoY

Operating margin

22% Industry: -147▼13.5% YoY

P/E ratio

18.6 Industry: 32▲87.9% YoY

Revenue & EBITDA

$1.3BFY2024 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends

Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

289.1M 2024▼156.1% YoY

Capex

161.0M 2024▲21.7% YoY

Debt/equity ratio

0.1 Industry: 1▼NaN% YoY

R&D intensity

10.3%FY2024

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

10.0%FY2026
Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals

Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

1.1

▼ 2.0%

2022

1.1

▼ 5.8%

2023

1.3

▼ 1.8%

2024

2.1

2027

Powered by illuminem

Asset manager exclusions

1 2026▼NaN% YoY

Exclusions by region

Reveal data for 2 credits

Institutions excluding by region out of total tracked institutions

Powered by illuminem and Covalence

Excluding institutions

Reveal data for 2 credits

Institution name, type, screener label

Powered by illuminem and Covalence

Environmental policy coverage

Carbon reduction policy

Available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Available

23%
Independent Directors

3 out of 13 incl. management

Powered by illuminem

Overall score

79

Environment

91

Social

83

Governance

63

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

 Available
Not committed to key sustainability initiatives

Sustainability employees

    Available in
    Scale package

    Access
  • Email
  • Email